RECURSION PHARMACEUTICALS, INC. (RXRX) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 36 days, typically, give or take 10 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 2, 2026after close 33 8-K
Q2 FY2026Wed, Aug 5, 2026before open 36 8-K
Q1 FY2026Wed, May 6, 2026before open 36 8-K
Q4 FY2025Wed, Feb 25, 2026before open 56 8-K
Q3 FY2025Wed, Nov 5, 2025before open 36 8-K
Q2 FY2025Tue, Aug 5, 2025before open 36 8-K
Q1 FY2025Mon, May 5, 2025before open 35 8-K
Q4 FY2024Fri, Feb 28, 2025before open 59 8-K

What they guided beta

Q3 FY2026 "Sanofi options the first development candidate from Recursion collaboration , a potential first-in-class, dual targeting inhibitor oral small molecule in immunology, which will now advance into Sanofi’s portfolio, with Phase 1 clinical study expected to begin in 2027." exhibit
Q3 FY2026 "Expected cash runway extended into 2029 , including proceeds from the October 2026 follow-on offering; 2026 cash operating expense guidance reiterated at less than $375 million, with 2027 guidance of less than $360 million." exhibit
Q3 FY2026 "The Company anticipates initiating a registrational trial in the second half of 2027, pending ongoing FDA discussions, and will provide additional details later this year." exhibit
Q3 FY2026 "Preliminary dose expansion data in endometrial cancer are expected in the second half of 2027." exhibit
Q3 FY2026 "The candidate has now been added to Sanofi’s development pipeline and is expected to enter Phase 1 clinical trials in 2027, with Sanofi funding and leading further development and commercialization to advance the program toward patients." exhibit
Q2 FY2026 "Reduced 2026 cash operating expense guidance to <$375 million (from <$390 million) SALT LAKE CITY, August 5, 2026 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates highlighting strong continued pipeline execution, clinical progress and platform advancement, as well as financial results for its second quarter ended June 30, 2026." exhibit
Q2 FY2026 "Session date and time: Monday November 2, 2026; 13:30 - 15:00 MST Phase 1/2 Trial Initiation for REC-7735 expected in 2H26:" exhibit
Q2 FY2026 "With the IND cleared, the Phase 1/2 ZINNIA clinical study for patients with select PIK3CA H1047R-mutant solid tumors will be initiated in the second half of 2026 For the rest of the portfolio, programs continue to progress as planned." exhibit
Q2 FY2026 "Based on current operating plans with no additional financing, the Company continues to expect its cash runway to extend into early 2028." exhibit
Q2 FY2026 "The Company is lowering its cash operating expense guidance for the full year 2026 by $15 million to $375 million based on additional identified operating efficiencies." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/RXRX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/RXRX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

RXRX earnings date badge

HTML

<a href="https://veritasdata.dev/company/RXRX/"><img src="https://veritasdata.dev/embed/RXRX.svg" alt="RXRX earnings date" width="240" height="56"></a>

Markdown

[![RXRX earnings date](https://veritasdata.dev/embed/RXRX.svg)](https://veritasdata.dev/company/RXRX/)

Script

<script async src="https://veritasdata.dev/embed/RXRX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/RXRX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.